Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 21, 2025 10:20 ET | Source: Research and Markets

Neurodegenerative Drugs Global Strategic Business Report 2025: Long-Term Growth and Innovations to 2030

Dublin, May 21, 2025 (GLOBE NEWSWIRE) -- The "Neurodegenerative Drugs - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Neurodegenerative...
March 22, 2022 05:53 ET | Source: Research and Markets

Global CNS Therapeutics Market to Cross $132 Billion by 2024 - Unmet Healthcare Needs for Detecting & Treating CNS Conditions Brings to Fore the Untapped Market Potential

Dublin, March 22, 2022 (GLOBE NEWSWIRE) -- The "CNS Therapeutics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global CNS Therapeutics...
June 16, 2021 07:23 ET | Source: Research and Markets

Global Anti-Parkinson Drugs Market Report 2021-2030 Featuring Major Players - GlaxoSmithKline, Pfizer, Merck, Novartis, Roche, UCB S.A, Teva Pharmaceuticals, AbbVie and Mylan

Dublin, June 16, 2021 (GLOBE NEWSWIRE) -- The "Anti-Parkinson Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering....
March 17, 2021 06:23 ET | Source: Research and Markets

Global Parkinson's Disease Treatment Industry (2020 to 2027) - Market Trajectory & Analytics

Dublin, March 17, 2021 (GLOBE NEWSWIRE) -- The "Parkinson's Disease Treatment - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the...
February 03, 2021 03:43 ET | Source: Research and Markets

Global Anti-Parkinson Drugs Market Report 2020: COVID-19, Growth and Change - Forecast to 2030

Dublin, Feb. 03, 2021 (GLOBE NEWSWIRE) -- The "Anti-Parkinson Drugs Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering....